CeriBell, Inc. (CBLL) Research
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Market snapshot
- Symbol
- CBLL
- Price
- $18.03
- Day change
- +4.34%
- Market cap
- $684.1M
- P/E ratio
- -11.25x
- 52-week range
- 10.85-24.33
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
- Analyst price target
- $25.00
Peer companies
Recent insider activity
- Taylor Joseph Michael — S-Sale (5500 shares) on 2026-06-11
- Chao Xingjuan — M-Exempt (23554 shares) on 2026-06-08
- Chao Xingjuan — M-Exempt (1446 shares) on 2026-06-08
- Chao Xingjuan — S-Sale (23554 shares) on 2026-06-08
- Chao Xingjuan — M-Exempt (1446 shares) on 2026-06-08
Open CeriBell, Inc. (CBLL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.